Now enrolling AR patients
ARTIST Trial – new treatment study. Learn more
We’re now enrolling patients with AR to participate in the ARTIST Trial, a research study evaluating a new treatment designed specifically for AR. Learn more
Hide ARTIST Trial banner
Videos

Aortic Regurgitation in 2022 - Undertreatment, Timing of Intervention, TAVR and Future Evidence Needs

James M. McCabe, Vinod H. Thourani, Nadira Hamid, Ravi Ramana and Mark J. Russo discuss JenaValve’s Trilogy System as a solution for severe AR patients in this symposium from the TVT meeting in 2022.